These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 38477525)

  • 21. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
    Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
    J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.
    Malik DG; Rath TJ; Urcuyo Acevedo JC; Canoll PD; Swanson KR; Boxerman JL; Quarles CC; Schmainda KM; Burns TC; Hu LS
    Front Radiol; 2022; 2():809373. PubMed ID: 37492687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
    Tietze A; Choi C; Mickey B; Maher EA; Parm Ulhøi B; Sangill R; Lassen-Ramshad Y; Lukacova S; Østergaard L; von Oettingen G
    J Neurosurg; 2018 Feb; 128(2):391-398. PubMed ID: 28298040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic algorithm for glioma grading using dynamic susceptibility contrast‑enhanced magnetic resonance perfusion and proton magnetic resonance spectroscopy.
    Nguyen DH; Nguyen DH; Le TD; Nguyen HK; Nguyen-Thi VA; Nguyen MD
    Biomed Rep; 2024 Mar; 20(3):56. PubMed ID: 38357240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
    van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
    Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
    Hyare H; Thust S; Rees J
    Curr Treat Options Neurol; 2017 Mar; 19(3):11. PubMed ID: 28349351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.
    Booth TC; Wiegers EC; Warnert EAH; Schmainda KM; Riemer F; Nechifor RE; Keil VC; Hangel G; Figueiredo P; Álvarez-Torres MDM; Henriksen OM
    Front Oncol; 2021; 11():811425. PubMed ID: 35340697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting.
    Cuccarini V; Antelmi L; Pollo B; Paterra R; Calatozzolo C; Nigri A; DiMeco F; Eoli M; Finocchiaro G; Brenna G; Tramacere I; Bruzzone MG; Anghileri E
    Neurol Sci; 2020 Feb; 41(2):347-355. PubMed ID: 31650436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced MR imaging in hemispheric low-grade gliomas before surgery; the indications and limits in the pediatric age.
    Gaudino S; Russo R; Verdolotti T; Caulo M; Colosimo C
    Childs Nerv Syst; 2016 Oct; 32(10):1813-22. PubMed ID: 27659824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
    Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
    Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
    Boxerman JL; Quarles CC; Hu LS; Erickson BJ; Gerstner ER; Smits M; Kaufmann TJ; Barboriak DP; Huang RH; Wick W; Weller M; Galanis E; Kalpathy-Cramer J; Shankar L; Jacobs P; Chung C; van den Bent MJ; Chang S; Al Yung WK; Cloughesy TF; Wen PY; Gilbert MR; Rosen BR; Ellingson BM; Schmainda KM;
    Neuro Oncol; 2020 Sep; 22(9):1262-1275. PubMed ID: 32516388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced MR imaging and
    Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-tumor histogram analysis of diffusion and perfusion metrics for noninvasive pediatric glioma grading.
    Su Y; Kang J; Lin X; She D; Guo W; Xing Z; Yang X; Cao D
    Neuroradiology; 2023 Jun; 65(6):1063-1071. PubMed ID: 37010573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
    Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced imaging techniques and non-invasive biomarkers in pediatric brain tumors: state of the art.
    Iacoban CG; Ramaglia A; Severino M; Tortora D; Resaz M; Parodi C; Piccardo A; Rossi A
    Neuroradiology; 2024 Oct; ():. PubMed ID: 39382639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.